Related Experiment Video
Updated: Jul 14, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Public opinion on needle and syringe programmes: avoiding assumptions for policy and practice.
Carla Treloar1, Suzanne Fraser
1National Centre in HIV Social Research, University of New South Wales, Australia. c.treloar@unsw.edu.au
Drug and Alcohol Review
|June 15, 2007
Summary
Community attitudes towards needle and syringe programmes (NSPs) in Australia are largely positive, contrary to policy assumptions. This research supports challenging negative publicity and reactionary policy decisions regarding harm reduction services.
Area of Science:
- Public Health
- Social Sciences
Background:
- Harm reduction services, such as needle and syringe programmes (NSPs), face challenges due to perceived community disapproval.
- Australian research on community attitudes towards NSPs is limited but crucial for policy and practice.
Purpose of the Study:
- To review Australian research on community attitudes toward harm reduction services, specifically NSPs.
- To analyze the impact of community perceptions on research, policy, and practice in Australia.
Main Methods:
- Literature review of Australian research on community attitudes to NSPs.
- Analysis of national samples and local community surveys.
Main Results:
- Contrary to common belief, community perceptions of NSPs in Australia are predominantly positive.
- Support for NSPs does not equate to condoning illicit drug use.
- Limited data are often misinterpreted by policymakers, leading to policy constraints.
Conclusions:
- Positive community attitudes towards NSPs should encourage researchers, practitioners, and policymakers to counter negative publicity and reactionary policy.
- Evidence of positive community support can challenge political responses and inform better policy decisions for harm reduction services.
Related Concept Videos
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:29Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:17Healthcare Agencies II
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
01:26Methods Of Healthcare Delivery System
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...